Klaria Pharma Holding AB (KLAR) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.004x

Based on the latest financial reports, Klaria Pharma Holding AB (KLAR) has a cash flow conversion efficiency ratio of 0.004x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-82.00K ≈ $-8.82K USD) by net assets (Skr-20.61 Million ≈ $-2.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See debt-free asset ratio of Klaria Pharma Holding AB to measure how much of total assets are equity-financed.

Klaria Pharma Holding AB - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Klaria Pharma Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Klaria Pharma Holding AB to evaluate the quality of earnings relative to operating cash generation.

Klaria Pharma Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Klaria Pharma Holding AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
The Navakij Insurance Public Company Limited BK:NKI	0.057x
FNC Entertainment Co Ltd KQ:173940	-0.285x
Globalsat Worldcom TWO:3499	0.002x
Vibhor Steel Tubes Limited NSE:VSTL	0.059x
AVOD Kurutulmus Gida ve Tarim Urunleri Sanayi Ticaret AS IS:AVOD	0.117x
Planet Green Holdings Corp NYSE MKT:PLAG	0.211x
Eastparc Hotel Tbk PT JK:EAST	0.017x
Gabungan AQRS Bhd KLSE:5226	-0.112x

Annual Cash Flow Conversion Efficiency for Klaria Pharma Holding AB (2015–2025)

The table below shows the annual cash flow conversion efficiency of Klaria Pharma Holding AB from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see KLAR company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr-3.88 Million ≈ $-417.44K	Skr-35.04 Million ≈ $-3.77 Million	9.032x	+350.12%
2024-12-31	Skr3.31 Million ≈ $355.67K	Skr-11.94 Million ≈ $-1.28 Million	-3.611x	-1539.91%
2023-12-31	Skr41.13 Million ≈ $4.43 Million	Skr-9.06 Million ≈ $-974.79K	-0.220x	+66.31%
2022-12-31	Skr76.08 Million ≈ $8.19 Million	Skr-49.73 Million ≈ $-5.35 Million	-0.654x	-82.97%
2021-12-31	Skr69.42 Million ≈ $7.47 Million	Skr-24.80 Million ≈ $-2.67 Million	-0.357x	-10.92%
2020-12-31	Skr109.59 Million ≈ $11.79 Million	Skr-35.30 Million ≈ $-3.80 Million	-0.322x	-78.73%
2019-12-31	Skr82.11 Million ≈ $8.84 Million	Skr-14.80 Million ≈ $-1.59 Million	-0.180x	-86.99%
2018-12-31	Skr94.70 Million ≈ $10.19 Million	Skr-9.13 Million ≈ $-982.10K	-0.096x	-22.67%
2017-12-31	Skr153.52 Million ≈ $16.52 Million	Skr-12.06 Million ≈ $-1.30 Million	-0.079x	+12.65%
2016-12-31	Skr160.04 Million ≈ $17.22 Million	Skr-14.39 Million ≈ $-1.55 Million	-0.090x	-254.52%
2015-12-31	Skr174.59 Million ≈ $18.79 Million	Skr-4.43 Million ≈ $-476.63K	-0.025x	--

About Klaria Pharma Holding AB

ST:KLAR Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$22.50 Million

Skr209.08 Million SEK

Market Cap Rank

#24683 Global

#495 in Sweden

Share Price

Skr0.85

Change (1 day)

-1.16%

52-Week Range

Skr0.45 - Skr1.22

All Time High

Skr17.00